{"id":"https://openalex.org/W2755198802","doi":null,"title":"Implications for future adverse effect studies of neuraminidase inhibitors (Rapid response to Neuraminidase inhibitors for preventing and treatinginfluenza in healthy adults: systematic review and meta-analysis byJefferson et al. BMJ 2009; 339: b5106).","display_name":"Implications for future adverse effect studies of neuraminidase inhibitors (Rapid response to Neuraminidase inhibitors for preventing and treatinginfluenza in healthy adults: systematic review and meta-analysis byJefferson et al. BMJ 2009; 339: b5106).","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2755198802","mag":"2755198802"},"language":"en","primary_location":{"id":"mag:2755198802","doi":null,"is_oa":false,"landing_page_url":"https://okayama.pure.elsevier.com/en/publications/implications-for-future-adverse-effect-studies-of-neuraminidase-i","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"BMJ","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017403216","display_name":"Toshihide Tsuda","orcid":"https://orcid.org/0000-0003-3962-8199","observed_orcids":["https://orcid.org/0000-0003-3962-8199"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Toshihide Tsuda","raw_affiliation_strings":["Faculty of Environmental Science and Technology"],"raw_orcid":"https://orcid.org/0000-0003-3962-8199","affiliations":[{"raw_affiliation_string":"Faculty of Environmental Science and Technology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5017403216"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0921,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.78017363,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuraminidase-inhibitors","display_name":"neuraminidase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.8149999976158142},{"id":"https://openalex.org/keywords/influenza-prevention","display_name":"influenza prevention","score":0.8050000071525574},{"id":"https://openalex.org/keywords/influenza-treatment","display_name":"influenza treatment","score":0.9559999704360962},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.7170000076293945},{"id":"https://openalex.org/keywords/healthy-adults","display_name":"healthy adults","score":0.7300000190734863}],"concepts":[{"id":"https://openalex.org/C134164806","wikidata":"https://www.wikidata.org/wiki/Q409485","display_name":"Neuraminidase","level":3,"score":0.9156349897384644},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.7224189639091492},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5639328956604004},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5447787046432495},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.38206174969673157},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.324332594871521},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2678195536136627},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25083911418914795},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1996733546257019},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18090370297431946},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.05124357342720032}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2755198802","doi":null,"is_oa":false,"landing_page_url":"https://okayama.pure.elsevier.com/en/publications/implications-for-future-adverse-effect-studies-of-neuraminidase-i","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"BMJ","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2771635210","https://openalex.org/W4254998480","https://openalex.org/W1987284356","https://openalex.org/W2409051612","https://openalex.org/W2149955368","https://openalex.org/W6892111053","https://openalex.org/W7098952027","https://openalex.org/W2411777732","https://openalex.org/W1575085722","https://openalex.org/W2093867498"],"abstract_inverted_index":null,"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2017-09-25T00:00:00"}